OTCMKTS:EKTAY Elekta Q2 2026 Earnings Report $5.09 0.00 (0.00%) As of 09/25/2026 01:10 PM Eastern ProfileEarnings HistoryForecast Elekta EPS ResultsActual EPS$0.07Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AElekta Revenue ResultsActual Revenue$427.85 millionExpected Revenue$436.91 millionBeat/MissMissed by -$9.06 millionYoY Revenue GrowthN/AElekta Announcement DetailsQuarterQ2 2026Date11/26/2025TimeN/AConference Call DateN/AConference Call TimeN/AUpcoming EarningsElekta's next earnings date is estimated for Wednesday, November 25, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Elekta Earnings HeadlinesElekta Broadens Adaptive Radiotherapy Portfolio Across ModalitiesSeptember 27 at 12:11 PM | tipranks.comInsulet (NASDAQ:PODD) & Elekta (OTCMKTS:EKTAY) Critical ComparisonSeptember 27 at 8:14 AM | americanbankingnews.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. | Stansberry Research (Ad)Elekta AGM Approves Dividend, Board Mandates and New Incentive PlanSeptember 3, 2026 | tipranks.comElekta AB earnings call: margins up, growth unevenAugust 27, 2026 | tipranks.comElekta AB (publ) (EKTAY) Q1 2027 Earnings Call TranscriptAugust 27, 2026 | seekingalpha.comSee More Elekta Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Elekta? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elekta and other key companies, straight to your email. Email Address About ElektaElekta (OTCMKTS:EKTAY) is a Sweden-based medical technology company focused on radiation oncology and precision treatment solutions. The company develops and supplies systems used to diagnose, plan and deliver treatments for cancer and other conditions affecting the brain and nervous system. Its product portfolio includes linear accelerators for external-beam radiotherapy, stereotactic radiosurgery systems such as Leksell Gamma Knife, brachytherapy equipment and treatment-planning, oncology information and workflow software. Elekta also provides related services, support and upgrades for healthcare providers. Founded in 1972 by neurosurgeon Lars Leksell, Elekta has grown into an international supplier serving hospitals, clinics and cancer centers across Europe, North and South America, Asia-Pacific, the Middle East and Africa. The company is headquartered in Stockholm, Sweden, and its shares trade on Nasdaq Stockholm under the symbol “EKTA”; its American depositary shares trade over the counter under the symbol “EKTAY.”View Elekta ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/21 - 09/252 Cybersecurity Stocks Breaking Out as AI Continues to Be a TailwindCostco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem5 Scary-Good Stocks With Strong October Catalysts and Breakout PotentialDarden Restaurants Serves Up Fresh Catalysts for a Stock Price RallySoFi Is Bypassing the Banking Bottleneck With Stablecoin Settlement Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
